SCHEMBL15087113

SCHEMBL15087113

C(=C/[Si](c1ccccc1)(c1ccccc1)c1ccccc1)\c1ccc(N(c2ccccc2)c2ccc3ccccc3c2)cc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RELA Q04206 2/20 0.45
MAPT P10636 3/20 0.36
ALDH1A1 P00352 3/20 0.36
GLA P06280 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
KDM4E B2RXH2 3/20 0.35
L3MBTL1 Q9Y468 3/20 0.35
MEN1 O00255 1/20 0.35
MAPK1 P28482 1/20 0.35
RAB9A P51151 1/20 0.35
KMT2A Q03164 1/20 0.35
RXFP1 Q9HBX9 1/20 0.35
PTGS1 P23219 1/20 0.34
CYP1B1 Q16678 1/20 0.34
APP P05067 1/20 0.34
CYP1A2 P05177 1/20 0.33
CYP3A4 P08684 1/20 0.33
CYP2D6 P10635 1/20 0.33
CYP2C9 P11712 1/20 0.33
CYP2C19 P33261 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13930387 0.98 RELA (0.46) RELAMAPTALDH1A1GLASMN1; SMN2
SCHEMBL15087180 0.98 RELA (0.46) RELAMAPTALDH1A1GLASMN1; SMN2
SCHEMBL15087128 0.96 RELA (0.41) RELAMAPTALDH1A1GLASMN1; SMN2
SCHEMBL15087169 0.90 RELA (0.50) RELAMAPTALDH1A1GLASMN1; SMN2
SCHEMBL15087173 0.89 RELA (0.41) RELAMAPTALDH1A1SMN1; SMN2KDM4E
SCHEMBL15087112 0.89 RELA (0.41) RELAMAPTALDH1A1SMN1; SMN2KDM4E
SCHEMBL15087166 0.88 RELA (0.44) RELAMAPTALDH1A1SMN1; SMN2KDM4E
SCHEMBL15087160 0.87 RELA (0.38) RELAMAPTALDH1A1KDM4EL3MBTL1
SCHEMBL13358524 0.86 RELA (0.60) RELAMAPTALDH1A1GLASMN1; SMN2
SCHEMBL12337350 0.86 RELA (0.60) RELAMAPTALDH1A1GLASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9401481-B2 Compound and organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2016-07-26 US disclosed
US-9401481-B2 Compound and organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2016-07-26 US disclosed
US-20130168646-A1 NOVEL COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2013-07-04 US disclosed
US-20130168646-A1 NOVEL COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2013-07-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130168646-A1 NOVEL COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME AOX1, OCIAD1, LEF1 RELA 1725/4885MAPT 2070/4885ALDH1A1 22/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.